NCT03523455

Iron Aid IPS on Performance, Fatigue and Iron Levels During 12 Weeks of Supplementation and Aerobic Training

Terminated NA Last updated 8 August 2018

What this trial tests

NA trial testing Iron Aid IPS (Iron Protein Succinylate) in Iron-deficiency in 2 participants. Terminated before completion.

Timeline

29 November 2016

Primary endpoint
11 November 2017

11 November 2017

Quick facts

Lead sponsor	University of Mary Hardin-Baylor
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	other
Enrollment	2
Start date	29 November 2016
Primary completion	11 November 2017
Estimated completion	11 November 2017
Sites	1 location across United States

Drugs / interventions tested

• Iron Aid IPS (Iron Protein Succinylate)
• Sugar Pill

Conditions studied

• Iron-deficiency — all drugs for Iron-deficiency →

Sponsor

University of Mary Hardin-Baylor

Who can join

Adults 18 to 30, female only, with Iron-deficiency. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Participants are required to undergo a screening and qualification before beginning the study. Once qualified, baseline testing is completed in the laboratory. This testing includes: body composition measurements, a blood draw, questionnaires, a VO2 max test, and a time to exhaustion trial. This testing is repeated during week 4 and week 12. At week 8, subjects complete a blood draw and questionnaires only. During the 12 week period, participants will follow an endurance exercise program in which they will train 4 days per week. This is a double-blind study in which participants are randomized into either the placebo or supplement group. They are instructed to ingest the supplement once a day at breakfast. Diet logs are also monitored throughout the duration of the study with the restriction of no red meat.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.